We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Danish Regulator Clarifies Trial Safety Information Requirements
Danish Regulator Clarifies Trial Safety Information Requirements
November 11, 2013
Sponsors and sites should base potential adverse reaction profiles of drugs in clinical trials on previously observed events, rather than anticipated pharmacological properties, the Danish Health and Medicines Authority says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor